gilles houvenaeghel
Institut Paoli-Calmettes (IPC)
Marseille, France
Associate Editor
Breast Cancer
Type at least 3 characters
Editors
Shape the future of research in your field
Join the board
Associate Editors
david d howell
OhioHealth
Columbus, United States
Associate Editor
Radiation Oncology
shih-min hsia
School of Nutrition and Health Sciences, College of Nutrition, Taipei Medical University
Taipei, Taiwan
Associate Editor
Pharmacology of Anti-Cancer Drugs
jason chia-hsun hsieh
Linkou Chang Gung Memorial Hospital
Linkou, Taiwan
Associate Editor
Head and Neck Cancer
ming-jen hsu
Taipei Medical University
Taipei, Taiwan
Associate Editor
Pharmacology of Anti-Cancer Drugs
baoli hu
University of Pittsburgh
Pittsburgh, United States
Associate Editor
Neuro-Oncology and Neurosurgical Oncology
hong-ming hu
Other
Shanghai, China
Associate Editor
Cancer Immunity and Immunotherapy
jethro hu
Cedars Sinai Medical Center
Los Angeles, United States
Associate Editor
Neuro-Oncology and Neurosurgical Oncology
jiankun hu
West China Hospital, Sichuan University
Chengdu, China
Associate Editor
Surgical Oncology
ronggui cory hu
Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (CAS)
Shanghai, China
Associate Editor
Molecular and Cellular Oncology
shimin hu
Department of Hematopathology, University of Texas MD Anderson Cancer Center
Houston, United States
Associate Editor
Hematologic Malignancies
yanle hu
Mayo Clinic Arizona
Scottsdale, United States
Associate Editor
Cancer Imaging and Image-directed Interventions
zhiwei hu
The Ohio State University
Columbus, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
chia-ho hua
St. Jude Children's Research Hospital
Memphis, United States
Associate Editor
Radiation Oncology
alex yee-chen huang
School of Medicine, Case Western Reserve University
Cleveland, United States
Associate Editor
Cancer Immunity and Immunotherapy
fang-ping huang
Institute for Advanced Study, Shenzhen University
Shenzhen, China
Associate Editor
Cancer Immunity and Immunotherapy